Company Filing History:
1 out of 13 
1 out of 219 
1 out of 832,880 Years Active: 2004-2005
Title: The Innovations of Thomas J Chambers
Introduction
Thomas J Chambers is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of virology, particularly in the development of chimeric flavivirus vaccines. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
Chambers' latest patents focus on chimeric flavivirus vaccines. These vaccines involve a chimeric live, infectious, attenuated virus containing a yellow fever virus. The nucleotide sequence for a prM-E protein is either deleted, truncated, or mutated, preventing the expression of functional prM-E protein. This sequence is integrated into the genome of the yellow fever virus, along with a nucleotide sequence encoding a prM-E protein of a second, different flavivirus. This innovative approach allows for the expression of the prM-E protein of the second flavivirus, enhancing the vaccine's effectiveness.
Career Highlights
Throughout his career, Thomas J Chambers has worked with various organizations, including Acambis Inc. His expertise in vaccine development has positioned him as a key figure in the field. His contributions have been instrumental in advancing the understanding and treatment of flavivirus-related diseases.
Collaborations
Chambers has collaborated with notable professionals in his field, including Thomas P Monath and Farshad Guirakhoo. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.
Conclusion
Thomas J Chambers is a distinguished inventor whose work in chimeric flavivirus vaccines showcases his commitment to advancing medical science. His patents reflect a significant step forward in vaccine technology, promising to enhance public health outcomes.